Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Shire reports earnings

Shire (LSE:SHP; SHPGY) reported non-GAAP diluted earnings per ADS of $0.66, up 32% from $0.50

Read the full 152 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE